KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Profit After Tax (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 147.05%
Dec 31, 2025 -50.75%
Sep 30, 2025 109,950.00%
Jun 30, 2025 -99.92%
Mar 31, 2025 3,936.07%
Dec 31, 2024 -94.98%
Sep 30, 2024 -27.68%
Jun 30, 2024 114.10%
Mar 31, 2024 -775.99%
Dec 31, 2023 -8.89%
Sep 30, 2023 48,250.00%
Jun 30, 2023 -20.00%
Mar 31, 2023 -99.75%
Dec 31, 2022 26.87%
Sep 30, 2022 13.16%
Jun 30, 2022 28,320.00%
Mar 31, 2022 -99.79%
Dec 31, 2021 54.72%
Sep 30, 2021 46.54%
Jun 30, 2021 -47.80%
Mar 31, 2021 120.16%
Dec 31, 2020 -633.92%
Sep 30, 2020 2,309.41%
Jun 30, 2020 89.03%
Mar 31, 2020 26.61%
Dec 31, 2019 -177.31%
Sep 30, 2019 -4.61%
Jun 30, 2019 -16.50%
Mar 31, 2019 48.10%
Dec 31, 2018 -39.08%
Sep 30, 2018 397.64%
Jun 30, 2018 -74.29%
Mar 31, 2018 163.80%
Dec 31, 2017 -375.62%
Sep 30, 2017 -7.75%
Jun 30, 2017 -39.97%
Mar 31, 2017 69.93%
Dec 31, 2016 -26.09%
Sep 30, 2016 4.20%
Jun 30, 2016 -2.43%
Mar 31, 2016 706.60%
Dec 31, 2015 -126.99%
Sep 30, 2015 661.54%
Jun 30, 2015 -110.84%
Mar 31, 2015 4,340.74%
Dec 31, 2014 -96.31%
Sep 30, 2014 119.16%
Jun 30, 2014 -64.35%
Mar 31, 2014 29.06%
Dec 31, 2013 4.91%
Sep 30, 2013 29.10%
Jun 30, 2013 -13.96%
Mar 31, 2013 -32.58%
Dec 31, 2012 229.96%
Sep 30, 2012 -210.23%
Jun 30, 2012 -41.42%
Mar 31, 2012 29.23%
Dec 31, 2011 -12.07%
Sep 30, 2011 -25.86%
Jun 30, 2011 -4.39%
Mar 31, 2011 62.35%
Dec 31, 2010 -35.33%
Sep 30, 2010 2.68%
Jun 30, 2010 15.17%
Mar 31, 2010 -86.28%
Dec 31, 2009 569.31%
Sep 30, 2009 21.97%
Jun 30, 2009 6.85%